Kyle Guse

CIK: 0001566618

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)2 (33.3%)

Derivative conversions

Awards (A)4 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CNSY

CERENOME, INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (6 total)

CNSY
CERENOME, INC.
Oct 1, 2026
Exercise(M)
Direct
921 shares-
PSTV
PLUS THERAPEUTICS, INC.
Jul 1, 2026
Exercise(M)
Direct
922 shares-
PSTV
PLUS THERAPEUTICS, INC.
May 14, 2026
Award(A)
Restricted Stock Units
Direct
3.7K shares-
PSTV
PLUS THERAPEUTICS, INC.
May 14, 2026
Award(A)
Stock Option (Right to Buy)
Direct
3.7K shares-
PSTV
PLUS THERAPEUTICS, INC.
Aug 13, 2025
Award(A)
Stock Option (Right to Buy)
Direct
297.8K shares-
PSTV
PLUS THERAPEUTICS, INC.
Aug 13, 2025
Award(A)
Stock Option (Right to Buy)
Direct
40K shares-

		Type	Shares	Price		Ownership
Oct 1, 2026	CNSY CERENOME, INC.	Exercise(M)	921	-	$0	Direct
Jul 1, 2026	PSTV PLUS THERAPEUTICS, INC.	Exercise(M)	922	-	$0	Direct
May 14, 2026	PSTV PLUS THERAPEUTICS, INC.	Award(A) Restricted Stock Units	3,686	-	-	Direct
May 14, 2026	PSTV PLUS THERAPEUTICS, INC.	Award(A) Stock Option (Right to Buy)	3,686	-	-	Direct
Aug 13, 2025	PSTV PLUS THERAPEUTICS, INC.	Award(A) Stock Option (Right to Buy)	297,794	-	-	Direct
Aug 13, 2025	PSTV PLUS THERAPEUTICS, INC.	Award(A) Stock Option (Right to Buy)	40,000	-	-	Direct

1-6 of 6 transactions

About Guse Kyle

Guse Kyle (SEC CIK 0001566618) files insider reports with the SEC as Director of CERENOME, INC. (CNSY).

Signal8 holds 5 ownership filings by Guse Kyle (1 Form 3, 4 Form 4), filed between Aug 15, 2025 and Oct 1, 2026. Those filings report 6 transactions, from Aug 13, 2025 to Oct 1, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Guse Kyle's filings is in HOUSTON, TX.

Recent filings by Guse Kyle

Oct 1, 2026: Option exercise of CNSY shares (Form 4, code M).
Jul 1, 2026: Option exercise of PSTV shares (Form 4, code M).
May 14, 2026: Grants or awards of PSTV derivative securities (2 lines, Form 4, code A).
Aug 13, 2025: Grants or awards of PSTV derivative securities (2 lines, Form 4, code A).

Other insiders filing for CERENOME, INC. (CNSY)

van Es-Johansson An, Director
Hawkins Richard J, Director
Clowes Howard, Director
Sims Andrew John Hugh MacIntyre, Chief Financial Officer
HEDRICK MARC H, Chief Executive Officer
ANDREWS RONALD ASBURY, Director

How to read Form 4 transaction codes